Longitudinal microperimetry evaluation after intravitreal ocriplasmin injection for vitreomacular traction

Andrea Cacciamani, Aldo Gelso, Joseph M. Simonett, Guido Ripandelli, Marco Pileri, Mario Stirpe, Fabio Scarinci

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To determine whether improvements in microperimetry testing are associated with anatomic resolution after ocriplasmin treatment in patients with symptomatic vitreomacular adhesion (VMA)/vitreomacular traction and relatively preserved baseline best-corrected visual acuity (BCVA). Methods: Patients with vitreomacular traction received a single 125-g intravitreal ocriplasmin injection and were followed longitudinally for 6 months with optical coherence tomography, BCVA testing, and microperimetry. Visual function changes were compared between eyes with and without VMA resolution on optical coherence tomography. Results: Eleven of 16 eyes (68.8%) achieved VMA resolution after treatment. Mean baseline BCVA was relatively good (79 ± 3 Early Treatment Diabetic Retinopathy Study letters; 20/52); no patients had a ≥2-line improvement in BCVA over the 6-month follow-up period. In the group with VMA resolution, mean retinal sensitivity significantly increased in the central 4° (15.2 ± 1.9 dB vs. 18.9 ± 0.7 dB, P < 0.001) when comparing baseline and final follow-up microperimetry testing. No change in mean retinal sensitivity was found in the group without VMA resolution. Conclusion: Microperimetry demonstrates a significant gain in retinal sensitivity, particularly in the central 4° area, in eyes with anatomic resolution after treatment of vitreomacular traction with intravitreal ocriplasmin injection, even when no significant gain in BCVA is seen.

Original languageEnglish
Pages (from-to)1832-1838
Number of pages7
JournalRetina
Volume37
Issue number10
DOIs
Publication statusPublished - Oct 1 2017

Fingerprint

Intravitreal Injections
Traction
Visual Acuity
Optical Coherence Tomography
Diabetic Retinopathy
Therapeutics
microplasmin

Keywords

  • microperimetry
  • ocriplasmin
  • vitreomacular traction

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Longitudinal microperimetry evaluation after intravitreal ocriplasmin injection for vitreomacular traction. / Cacciamani, Andrea; Gelso, Aldo; Simonett, Joseph M.; Ripandelli, Guido; Pileri, Marco; Stirpe, Mario; Scarinci, Fabio.

In: Retina, Vol. 37, No. 10, 01.10.2017, p. 1832-1838.

Research output: Contribution to journalArticle

@article{7c7b93025bbd4420a91131eb0c5f23af,
title = "Longitudinal microperimetry evaluation after intravitreal ocriplasmin injection for vitreomacular traction",
abstract = "Purpose: To determine whether improvements in microperimetry testing are associated with anatomic resolution after ocriplasmin treatment in patients with symptomatic vitreomacular adhesion (VMA)/vitreomacular traction and relatively preserved baseline best-corrected visual acuity (BCVA). Methods: Patients with vitreomacular traction received a single 125-g intravitreal ocriplasmin injection and were followed longitudinally for 6 months with optical coherence tomography, BCVA testing, and microperimetry. Visual function changes were compared between eyes with and without VMA resolution on optical coherence tomography. Results: Eleven of 16 eyes (68.8{\%}) achieved VMA resolution after treatment. Mean baseline BCVA was relatively good (79 ± 3 Early Treatment Diabetic Retinopathy Study letters; 20/52); no patients had a ≥2-line improvement in BCVA over the 6-month follow-up period. In the group with VMA resolution, mean retinal sensitivity significantly increased in the central 4° (15.2 ± 1.9 dB vs. 18.9 ± 0.7 dB, P < 0.001) when comparing baseline and final follow-up microperimetry testing. No change in mean retinal sensitivity was found in the group without VMA resolution. Conclusion: Microperimetry demonstrates a significant gain in retinal sensitivity, particularly in the central 4° area, in eyes with anatomic resolution after treatment of vitreomacular traction with intravitreal ocriplasmin injection, even when no significant gain in BCVA is seen.",
keywords = "microperimetry, ocriplasmin, vitreomacular traction",
author = "Andrea Cacciamani and Aldo Gelso and Simonett, {Joseph M.} and Guido Ripandelli and Marco Pileri and Mario Stirpe and Fabio Scarinci",
year = "2017",
month = "10",
day = "1",
doi = "10.1097/IAE.0000000000001432",
language = "English",
volume = "37",
pages = "1832--1838",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Longitudinal microperimetry evaluation after intravitreal ocriplasmin injection for vitreomacular traction

AU - Cacciamani, Andrea

AU - Gelso, Aldo

AU - Simonett, Joseph M.

AU - Ripandelli, Guido

AU - Pileri, Marco

AU - Stirpe, Mario

AU - Scarinci, Fabio

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Purpose: To determine whether improvements in microperimetry testing are associated with anatomic resolution after ocriplasmin treatment in patients with symptomatic vitreomacular adhesion (VMA)/vitreomacular traction and relatively preserved baseline best-corrected visual acuity (BCVA). Methods: Patients with vitreomacular traction received a single 125-g intravitreal ocriplasmin injection and were followed longitudinally for 6 months with optical coherence tomography, BCVA testing, and microperimetry. Visual function changes were compared between eyes with and without VMA resolution on optical coherence tomography. Results: Eleven of 16 eyes (68.8%) achieved VMA resolution after treatment. Mean baseline BCVA was relatively good (79 ± 3 Early Treatment Diabetic Retinopathy Study letters; 20/52); no patients had a ≥2-line improvement in BCVA over the 6-month follow-up period. In the group with VMA resolution, mean retinal sensitivity significantly increased in the central 4° (15.2 ± 1.9 dB vs. 18.9 ± 0.7 dB, P < 0.001) when comparing baseline and final follow-up microperimetry testing. No change in mean retinal sensitivity was found in the group without VMA resolution. Conclusion: Microperimetry demonstrates a significant gain in retinal sensitivity, particularly in the central 4° area, in eyes with anatomic resolution after treatment of vitreomacular traction with intravitreal ocriplasmin injection, even when no significant gain in BCVA is seen.

AB - Purpose: To determine whether improvements in microperimetry testing are associated with anatomic resolution after ocriplasmin treatment in patients with symptomatic vitreomacular adhesion (VMA)/vitreomacular traction and relatively preserved baseline best-corrected visual acuity (BCVA). Methods: Patients with vitreomacular traction received a single 125-g intravitreal ocriplasmin injection and were followed longitudinally for 6 months with optical coherence tomography, BCVA testing, and microperimetry. Visual function changes were compared between eyes with and without VMA resolution on optical coherence tomography. Results: Eleven of 16 eyes (68.8%) achieved VMA resolution after treatment. Mean baseline BCVA was relatively good (79 ± 3 Early Treatment Diabetic Retinopathy Study letters; 20/52); no patients had a ≥2-line improvement in BCVA over the 6-month follow-up period. In the group with VMA resolution, mean retinal sensitivity significantly increased in the central 4° (15.2 ± 1.9 dB vs. 18.9 ± 0.7 dB, P < 0.001) when comparing baseline and final follow-up microperimetry testing. No change in mean retinal sensitivity was found in the group without VMA resolution. Conclusion: Microperimetry demonstrates a significant gain in retinal sensitivity, particularly in the central 4° area, in eyes with anatomic resolution after treatment of vitreomacular traction with intravitreal ocriplasmin injection, even when no significant gain in BCVA is seen.

KW - microperimetry

KW - ocriplasmin

KW - vitreomacular traction

UR - http://www.scopus.com/inward/record.url?scp=85007413327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007413327&partnerID=8YFLogxK

U2 - 10.1097/IAE.0000000000001432

DO - 10.1097/IAE.0000000000001432

M3 - Article

AN - SCOPUS:85007413327

VL - 37

SP - 1832

EP - 1838

JO - Retina

JF - Retina

SN - 0275-004X

IS - 10

ER -